APA

Ferretti G., Bria E., Giannarelli D., Felici A., Papaldo P., Fabi A., Di Cosimo S., Ruggeri E. M., Milella M., Ciccarese M., Cecere F. L., Gelibter A., Nuzzo C., Cognetti F., Terzoli E. & Carlini P. (20060804). Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials. : British journal of cancer.

Chicago

Ferretti G, Bria E, Giannarelli D, Felici A, Papaldo P, Fabi A, Di Cosimo S, Ruggeri E M, Milella M, Ciccarese M, Cecere F L, Gelibter A, Nuzzo C, Cognetti F, Terzoli E and Carlini P. 20060804. Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials. : British journal of cancer.

Harvard

Ferretti G., Bria E., Giannarelli D., Felici A., Papaldo P., Fabi A., Di Cosimo S., Ruggeri E. M., Milella M., Ciccarese M., Cecere F. L., Gelibter A., Nuzzo C., Cognetti F., Terzoli E. and Carlini P. (20060804). Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials. : British journal of cancer.

MLA

Ferretti G, Bria E, Giannarelli D, Felici A, Papaldo P, Fabi A, Di Cosimo S, Ruggeri E M, Milella M, Ciccarese M, Cecere F L, Gelibter A, Nuzzo C, Cognetti F, Terzoli E and Carlini P. Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials. : British journal of cancer. 20060804.